Citations 1
The role of highly selective androgen receptor (AR) targeted therapy in men with biochemically relapsed hormone sensitive prostate cancer.
Aggarwal, Rahul , Alumkal, Joshi J. , Higano, Celestia S. , Yu, Margaret K. , Boer, Carla de, Choque-Gonzales, Gonzalo, Szmulewitz, Russell Z , Bryce, Alan H. , Small, Eric J.
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS5084-TPS5084
